Low-grade lymphomas are potentially curable, but some patients have difficulty achieving good outcomes.
Lymphoma is divided into low-grade lymphoma and high-grade lymphoma. Low-grade lymphoma suggests that the malignant degree of lymphoma is relatively low, the prognosis is relatively good, and the cure rate is relatively high, but the cure rate is not 100%. High-grade lymphoma, on the other hand, suggests that the malignant degree of lymphoma is higher, the prognosis is poorer, and the cure rate is lower.
The current treatment for lymphoma is mainly chemotherapy and hematopoietic stem cell transplantation. Drugs include cyclophosphamide, vincristine, etc. Hematopoietic stem cell transplantation is mainly autologous hematopoietic stem cell transplantation, and a very small number of patients need allogeneic hematopoietic stem cell transplantation.
Lymphoma patients need to consult the hematology department for a thorough evaluation before treatment, and individualized treatment plans are developed under the guidance of physicians.